We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect GE HealthCare Technologies (GEHC - Free Report) to post quarterly earnings of $1.06 per share in its upcoming report, which indicates a year-over-year increase of 7.1%. Revenues are expected to be $4.86 billion, up 0.9% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific GE HealthCare metrics that are commonly monitored and projected by Wall Street analysts.
Analysts forecast 'Revenues- Imaging' to reach $2.63 billion. The estimate indicates a change of -0.3% from the prior-year quarter.
It is projected by analysts that the 'Revenues- Ultrasound' will reach $823.95 million. The estimate indicates a year-over-year change of +1.1%.
Analysts predict that the 'Revenues- Other' will reach $10.52 million. The estimate suggests a change of -44.6% year over year.
Analysts' assessment points toward 'Revenues- PDx' reaching $634.60 million. The estimate points to a change of +7.7% from the year-ago quarter.
The average prediction of analysts places 'Revenues- PCS' at $775.36 million. The estimate points to a change of +1.5% from the year-ago quarter.
GE HealthCare shares have witnessed a change of -3.9% in the past month, in contrast to the Zacks S&P 500 composite's +2% move. With a Zacks Rank #3 (Hold), GEHC is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts expect GE HealthCare Technologies (GEHC - Free Report) to post quarterly earnings of $1.06 per share in its upcoming report, which indicates a year-over-year increase of 7.1%. Revenues are expected to be $4.86 billion, up 0.9% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific GE HealthCare metrics that are commonly monitored and projected by Wall Street analysts.
Analysts forecast 'Revenues- Imaging' to reach $2.63 billion. The estimate indicates a change of -0.3% from the prior-year quarter.
It is projected by analysts that the 'Revenues- Ultrasound' will reach $823.95 million. The estimate indicates a year-over-year change of +1.1%.
Analysts predict that the 'Revenues- Other' will reach $10.52 million. The estimate suggests a change of -44.6% year over year.
Analysts' assessment points toward 'Revenues- PDx' reaching $634.60 million. The estimate points to a change of +7.7% from the year-ago quarter.
The average prediction of analysts places 'Revenues- PCS' at $775.36 million. The estimate points to a change of +1.5% from the year-ago quarter.
View all Key Company Metrics for GE HealthCare here>>>
GE HealthCare shares have witnessed a change of -3.9% in the past month, in contrast to the Zacks S&P 500 composite's +2% move. With a Zacks Rank #3 (Hold), GEHC is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>